We’re a team of serial entrepreneurs on a mission to revolutionize endoscopy.
Imagine a patient whose life hinges on a precise lung biopsy. Today, up to 35% of such cases require invasive surgeries like thoracotomies, which are riskier, costlier, and lead to higher complication rates. We’re changing that.
LumenGuides autonomous, location-aware bronchoscope is redefining lung diagnostics and treatment by:
Expanding Diagnostic Reach: Accessing previously unreachable areas, drastically reducing the need for invasive procedures.
AI-Powered Auto-Navigation: Combining real-time positioning with deep learning for unmatched precision.
Radiation-Free Precision: Eliminating reliance on harmful imaging techniques like X-rays.
Single-Use Sterility: Preventing cross-contamination and enhancing patient safety.
With a proven proof of concept and a bootstrap-funded team of serial entrepreneurs, we’re positioned to disrupt a $62.5B global market. Over 500,000 bronchoscopy procedures are performed annually in the U.S. , offering significant growth opportunities.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2024
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was LumenGuides founded?
LumenGuides was founded in 2024.
What industry is LumenGuides in?
LumenGuides operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Find investors for your startup like LumenGuides
Gritt sends AI-personalised outreach to each investor — from your Gmail
